INFINITY PHARMACEUTICALS, INC. 4
4 · INFINITY PHARMACEUTICALS, INC. · Filed Jun 16, 2015
Insider Transaction Report
Form 4
Palombella Vito J.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2015-06-15$10.97/sh−4,737$51,965→ 868 total
Holdings
- 6,741.146(indirect: By 401(k))
Common Stock
Footnotes (1)
- [F1]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $10.83 to $11.10, inclusive. The reporting person undertakes to provide to Infinity Pharmaceuticals, Inc., any security holder of Infinity Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 1.